Summary: Human skin is an effective barrier that blocks most large, water‑loving molecules, including many peptides. The stratum corneum’s “brick and mortar” structure sharply limits passive diffusion, so standard creams and gels rarely deliver meaningful peptide amounts into or through intact skin. Advanced systems—liposomes, solid lipid nanoparticles, polymeric nanocarriers, and CPP‑modified formulations—can improve skin penetration, especially when the barrier is disrupted or when local delivery is the goal. However, transdermal delivery for consistent systemic peptide exposure is still technically challenging, and injectable routes remain the standard. Research continues to push these boundaries, making future needle‑free peptide options more likely.
This research article explains how the skin barrier works, why most peptides do not penetrate easily, what new technologies like liposomes and nanoparticles bring to the table, and what the realistic current and future outlook looks like.
The Skin Barrier: Friend and Foe
The outermost layer of the skin, the stratum corneum, acts as a tough, protective shield. It is often described as a “brick and mortar” structure:
- The “bricks” are dead skin cells (corneocytes).
- The “mortar” is a lipid (fatty) matrix between these cells.
This structure is highly effective at:
- Preventing water loss from inside the body
- Blocking entry of many chemicals, microbes, and particles from outside
Transdermal delivery systems must either:
- Sneak through the spaces between cells (intercellular route)
- Go directly through cells (transcellular route)
- Use skin appendages like hair follicles and sweat glands (appendageal route)
For small, lipophilic (fat‑soluble) drugs with low dose requirements, standard patches can work well. But peptides present different challenges.
Why Peptides Struggle to Cross Intact Skin
Peptides are:
- Larger molecules than most classic transdermal drugs
- Often water‑soluble and polar
- Often charged at physiological pH
These features make it difficult for peptides to pass through the tightly packed lipids of the stratum corneum.
Reviews on nanoparticle‑enabled transdermal delivery highlight that conventional creams or gels rarely move intact peptide molecules deep into or through intact skin. Key reasons include:
- Size limitation: The skin favors small molecules—typically below 500 Daltons—for passive diffusion. Many peptides are well above this threshold.
- Hydrophilicity: Water‑loving peptides do not easily partition into the lipid‑rich barrier.
- Charge: Charged molecules interact unfavorably with the neutral lipid matrix.
As a result, without advanced formulation, most topically applied peptides remain in the very upper layers of the skin or on the surface, limiting systemic delivery and deeper action.
Nanoparticles and Liposomes: New Tools for Peptide Delivery
To overcome these barriers, researchers use nanoscale carriers that can interact with and sometimes partially bypass the stratum corneum.
Liposomes and Vesicular Systems
Liposomes are tiny spherical vesicles made of lipid bilayers, similar to cell membranes. They can encapsulate peptides in their water core or within the lipid layers.
For skin delivery, liposomal systems aim to:
- Enhance interaction with the skin surface
- Improve penetration into upper skin layers
- Protect peptides from degradation
Certain modified liposomes (for example, elastic or deformable vesicles) are designed to squeeze through tight spaces in the skin, although their ability to carry peptides fully across intact skin remains limited and often variable.
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers
These systems use solid or semi‑solid lipids to create stable nanoparticle carriers for peptides.
Potential advantages include:
- Improved stability of sensitive peptides
- Controlled release at the skin surface or within layers
- Enhanced interaction with the epidermis
Studies suggest that such systems may increase peptide retention in the skin and, under certain conditions, support deeper penetration.
Polymer‑Based Nanoparticles
Polymeric nanoparticles made from biodegradable materials can:
- Encapsulate peptides
- Interact with skin components
- Release drug over time
Reviews note that when small enough, these particles can enter viable skin layers, especially when the barrier is compromised or aided by other methods.
Skin Penetration Routes and Nanocarriers
Transdermal delivery via nanocarriers can follow three main routes:
- Intercellular route: particles or released peptides diffuse between corneocytes through lipid channels.
- Transcellular route: particles or molecules pass directly through cells, sometimes aided by cell‑penetrating peptides.
- Appendageal route: particles gather in hair follicles or sweat glands, then diffuse into nearby tissue.
Nanoparticles can accumulate in follicular openings, acting as local reservoirs that slowly release peptides into deeper skin layers.
However, even with nanocarriers, fully crossing the skin into systemic circulation remains challenging under normal, intact conditions.
Barrier‑Disrupted Skin and Local Delivery
An important concept is that many nanocarrier systems perform better when the skin barrier is disrupted or when the goal is local, not systemic, delivery.
Barrier disruption can occur due to:
- Inflammatory skin diseases like psoriasis or atopic dermatitis
- Mechanical damage (scratching, abrasion)
- Intentional methods like microneedles or controlled abrasion
In these contexts:
- Nanocarriers often penetrate deeper and can provide therapeutic amounts of drug locally.
- Peptides can act directly in the skin, for example in inflammatory conditions, without needing high systemic levels.
Reviews suggest that nanocarrier‑based systems may be particularly useful for treating skin diseases where the barrier is already compromised or where local action is enough.
Cell‑Penetrating Peptides and Hybrid Systems
Cell‑penetrating peptides (CPPs) are short sequences that can cross cell membranes and sometimes enhance cargo delivery.
Combining CPPs with nanoparticles or attaching peptides to CPPs may:
- Improve entry into skin cells
- Enhance translocation through deeper layers
Studies describe CPP‑modified nanocarriers achieving deeper skin penetration and increased drug activity in some models, though translation to consistent human systemic delivery is still under active investigation.
Current Limitations and Practical Reality
Despite promising research:
- Reliable, high‑level systemic delivery of peptides through intact human skin remains difficult.
- Most commercially successful transdermal systems still involve small, lipophilic drugs at low dose levels.
- Many peptide “topicals” primarily affect surface or superficial layers rather than deep tissue or whole‑body circulation.
Future systems may combine:
- Microneedles or physical enhancement (to open micro‑channels)
- Nanoparticles or liposomes (to carry and protect peptides)
- CPPs or chemical enhancers (to move peptides into cells and tissues)
But for now, injection and other parenteral routes remain the main ways to deliver peptides systemically.
